[1]
Ramasubbu, S.K., Dakshinamurthy, S., Palepu, S., Bandyopadhyay, A. and Rajendran, S.K. 2020. Rimegepant: first novel oral calcitonin gene-related peptide inhibitor for migraine. International Journal of Basic & Clinical Pharmacology. 9, 5 (Apr. 2020), 829–832. DOI:https://doi.org/10.18203/2319-2003.ijbcp20201768.